Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.
Researchers are collaborating with the NBA to create a new standard in the detection and reduction of cardiac risk among professional basketball athletes.
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a new study from Columbia researchers.
A new study has revealed that cholesterol-lowering statins may help reverse the mechanisms that increase the risk of heart disease in people with sleep apnea.
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
The NIH has granted $8.56 million for a first of its kind clinical trial examining cardiovascular disease in patients with rheumatoid arthritis. One of the principal investigators is Columbia's Joan Bathon.